COVID-19, Patents and Access to Healthcare: a French Perspective

9 Pages Posted: 31 May 2020

See all articles by Matthieu Dhenne

Matthieu Dhenne

Max Planck Institute for Innovation and Competition

Date Written: May 1, 2020

Abstract

While the coronavirus 19 (COVID-19) pandemic forced a large part of the world's population into quarantine, research into treatment and testing intensified. At the same time, patents have rarely been so much in the forefront: how can we ensure that access to care will not be hindered by patents? Should we opt for an ex-officio license, relax the conditions of this license, or even expropriate the patentees? A bill tabled on April 7, 2020 in the French “Assemblée Nationale” launches discussion in France.

Keywords: COVID-19, ex-officio licenses, compulsory licensing, patent, access to healthcare, France

Suggested Citation

Dhenne, Matthieu, COVID-19, Patents and Access to Healthcare: a French Perspective (May 1, 2020). Available at SSRN: https://ssrn.com/abstract=3614409 or http://dx.doi.org/10.2139/ssrn.3614409

Matthieu Dhenne (Contact Author)

Max Planck Institute for Innovation and Competition ( email )

Marstallplatz 1
Munich, Bayern 80539
Germany

HOME PAGE: http://https://www.ip.mpg.de

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
55
Abstract Views
554
rank
415,422
PlumX Metrics